Greenleaf Trust raised its stake in shares of MSCI Inc. (NYSE:MSCI – Free Report) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,684 shares of the technology company’s stock after purchasing an additional 54 shares during the period. Greenleaf Trust’s holdings in MSCI were worth $1,518,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. RB Capital Management LLC raised its position in shares of MSCI by 16.5% in the 1st quarter. RB Capital Management LLC now owns 1,276 shares of the technology company’s stock worth $642,000 after buying an additional 181 shares during the period. Markel Corp lifted its stake in shares of MSCI by 3.4% in the 1st quarter. Markel Corp now owns 141,700 shares of the technology company’s stock valued at $71,258,000 after purchasing an additional 4,700 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of MSCI by 42.2% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,237 shares of the technology company’s stock worth $622,000 after purchasing an additional 367 shares during the period. Cibc World Market Inc. increased its position in MSCI by 6.0% during the 1st quarter. Cibc World Market Inc. now owns 1,831 shares of the technology company’s stock worth $921,000 after purchasing an additional 104 shares in the last quarter. Finally, Prudential PLC purchased a new position in MSCI in the first quarter valued at approximately $701,000. Hedge funds and other institutional investors own 89.97% of the company’s stock.
MSCI Price Performance
MSCI opened at $510.07 on Friday. MSCI Inc. has a 12-month low of $451.55 and a 12-month high of $617.39. The stock has a market capitalization of $40.41 billion, a PE ratio of 35.42, a P/E/G ratio of 2.56 and a beta of 1.06. The firm’s fifty day moving average price is $552.00 and its 200 day moving average price is $539.16.
MSCI Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, February 29th. Shareholders of record on Friday, February 16th were issued a dividend of $1.60 per share. This represents a $6.40 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date of this dividend was Thursday, February 15th. This is an increase from MSCI’s previous quarterly dividend of $1.38. MSCI’s dividend payout ratio (DPR) is currently 44.44%.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on MSCI. Redburn Atlantic lowered shares of MSCI from a “neutral” rating to a “sell” rating and dropped their price objective for the stock from $620.00 to $470.00 in a research report on Tuesday, February 20th. Royal Bank of Canada restated an “outperform” rating and set a $638.00 price objective on shares of MSCI in a research note on Friday, April 12th. Wolfe Research started coverage on MSCI in a research note on Tuesday, March 26th. They issued a “peer perform” rating for the company. Wells Fargo & Company boosted their price target on MSCI from $615.00 to $660.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 31st. Finally, The Goldman Sachs Group increased their price objective on shares of MSCI from $544.00 to $617.00 and gave the company a “neutral” rating in a research report on Wednesday, January 31st. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the stock. According to MarketBeat, MSCI presently has a consensus rating of “Hold” and a consensus price target of $581.57.
Read Our Latest Stock Report on MSCI
MSCI Profile
MSCI Inc, together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.
Featured Articles
- Five stocks we like better than MSCI
- The How And Why of Investing in Oil Stocks
- MarketBeat Week in Review – 4/15 – 4/19
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Comprehensive Analysis of PayPal Stock
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for MSCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSCI and related companies with MarketBeat.com's FREE daily email newsletter.